Neuronetics Inc (STIM)

Aug 11, 2026, 8:30 AM EDT - 9 days ago

Neuronetics Earnings Call Transcript: Q2 2026

Aug 11, 2026, 8:30 AM EDT - 9 days ago

Neuronetics Slides: Q2 2026

Aug 11, 2026, 8:30 AM EDT - 9 days ago

Neuronetics Earnings release: Q2 2026

Aug 11, 2026, 8:30 AM EDT - 9 days ago

Neuronetics Quarterly report: Q2 2026

2026-08-11T11:55:20.000Z - 9 days ago

Neuronetics reports Q2 EPS (5c), consensus (12c)

Aug 3, 2026, 8:00 AM EDT - 17 days ago

Neuronetics and Jorey Chernett Announce Shared Vision

Jul 31, 2026, 5:00 PM EDT - 19 days ago

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jul 28, 2026, 8:32 AM EDT - 23 days ago

Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland

Jul 28, 2026, 8:30 AM EDT - 23 days ago

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

2026-07-20T20:15:49.000Z - 4 weeks ago

Neuronetics appoints Nir Naor as CFO, CLO Andrew Macan to step down

AXGN

Jul 20, 2026, 4:05 PM EDT - 4 weeks ago

Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes

2026-07-20T10:11:07.000Z - 4 weeks ago

Neuronetics initiated with a Buy at BTIG

Jul 6, 2026, 8:30 AM EDT - 6 weeks ago

Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026

Jun 2, 2026, 4:30 PM EDT - 2 months ago

Neuronetics Appoints Robert Greene as Senior Vice President Sales

Jun 2, 2026, 8:32 AM EDT - 2 months ago

Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026

May 28, 2026, 8:00 AM EDT - 3 months ago

Neuronetics Transcript: AGM 2026

May 14, 2026, 8:32 AM EDT - 3 months ago

Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment

2026-05-05T12:37:49.000Z - 3 months ago

Neuronetics reports Q1 EPS (16c), consensus (17c)

2026-05-05T12:33:13.000Z - 3 months ago

Neuronetics backs FY26 revenue view $160M-$166M, consensus $162.47M

May 5, 2026, 8:30 AM EDT - 3 months ago

Neuronetics Earnings Call Transcript: Q1 2026

May 5, 2026, 8:30 AM EDT - 3 months ago

Neuronetics Earnings release: Q1 2026

May 5, 2026, 8:30 AM EDT - 3 months ago

Neuronetics Slides: Q1 2026

May 5, 2026, 8:30 AM EDT - 3 months ago

Neuronetics Quarterly report: Q1 2026

May 5, 2026, 7:50 AM EDT - 3 months ago

Neuronetics Reports First Quarter 2026 Financial and Operating Results

Apr 21, 2026, 8:30 AM EDT - 4 months ago

Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call

Apr 13, 2026, 8:32 AM EDT - 4 months ago

Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners

Apr 9, 2026, 8:00 AM EDT - 4 months ago

Neuronetics Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 4 months ago

Neuronetics Proxy statement: Proxy filing

2026-04-06T20:41:11.000Z - 4 months ago

Neuronetics backs FY26 revenue view $160M-$166M, consensus $162.47M

2026-04-06T20:36:05.000Z - 4 months ago

Neuronetics CFO Steven Pfanstiel to depart

2026-04-06T20:35:09.000Z - 4 months ago

Neuronetics backs Q1 revenue view $33M-$35M, consensus $34.18M

2026-04-06T20:11:09.000Z - 4 months ago

Neuronetics’ largest independent shareholder urges review of alternatives

Apr 6, 2026, 4:05 PM EDT - 4 months ago

Largest Independent Shareholder of Neuronetics, Inc., Jorey Chernett, Calls for Immediate and Comprehensive Review of Strategic Alternatives, Including Sale of TMS Business

2026-03-19T10:45:58.000Z - 5 months ago

Neuronetics price target lowered to $3 from $7 at Canaccord

CMPS

2026-03-17T21:00:32.000Z - 5 months ago

Neuronetics files to sell 20.74M shares of common stock for holders

Mar 17, 2026, 8:30 AM EDT - 5 months ago

Neuronetics Earnings Call Transcript: Q4 2025

Mar 17, 2026, 8:30 AM EDT - 5 months ago

Neuronetics Annual report: Q4 2025

Mar 17, 2026, 8:30 AM EDT - 5 months ago

Neuronetics Earnings release: Q4 2025

Mar 17, 2026, 8:30 AM EDT - 5 months ago

Neuronetics Slides: Q4 2025

Mar 17, 2026, 8:00 AM EDT - 5 months ago

Neuronetics Registration statement: Registration Filing

2026-03-17T11:55:48.000Z - 5 months ago

Neuronetics reports Q4 EPS (10c) vs. (34c) last year

2026-03-17T11:55:39.000Z - 5 months ago

Neuronetics sees Q1 revenue $33M-$35M, consensus $37.22M

2026-03-17T11:55:14.000Z - 5 months ago

Neuronetics sees FY26 revenue $160M-$166M, consensus $164.15M

2026-03-17T11:50:30.000Z - 5 months ago

Neuronetics appoints Dan Reuvers as President and CEO

Mar 17, 2026, 7:50 AM EDT - 5 months ago

Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Mar 17, 2026, 7:45 AM EDT - 5 months ago

Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

2026-02-10T21:45:58.000Z - 6 months ago

Neuronetics reports preliminary Q4 revenue $41.8M, consensus $40.66M

2026-02-10T21:45:50.000Z - 6 months ago

Neuronetics sees FY25 revenue $149.2M, consensus $148.08M

Feb 10, 2026, 4:34 PM EST - 6 months ago

Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

Nov 20, 2025, 8:30 AM EST - 9 months ago

Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference

2025-11-13T17:55:32.000Z - 10 months ago

Neuronetics management to meet with Citizens JMP

Nov 12, 2025, 10:33 AM EST - 10 months ago

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

Nov 4, 2025, 8:30 AM EST - 10 months ago

Neuronetics Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:30 AM EST - 10 months ago

Neuronetics Quarterly report: Q3 2025

Nov 4, 2025, 8:30 AM EST - 10 months ago

Neuronetics Earnings release: Q3 2025

Nov 4, 2025, 8:30 AM EST - 10 months ago

Neuronetics Slides: Q3 2025

Nov 4, 2025, 7:05 AM EST - 10 months ago

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

Oct 30, 2025, 8:32 AM EDT - 10 months ago

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

Oct 21, 2025, 8:30 AM EDT - 10 months ago

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

Sep 17, 2025, 8:32 AM EDT - 1 year ago

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

Aug 5, 2025, 8:30 AM EDT - 1 year ago

Neuronetics Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:30 AM EDT - 1 year ago

Neuronetics Earnings release: Q2 2025

Aug 5, 2025, 8:30 AM EDT - 1 year ago

Neuronetics Quarterly report: Q2 2025

Aug 5, 2025, 8:30 AM EDT - 1 year ago

Neuronetics Slides: Q2 2025

Aug 4, 2025, 4:30 PM EDT - 1 year ago

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 30, 2025, 8:32 AM EDT - 1 year ago

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

Jul 15, 2025, 7:30 AM EDT - 1 year ago

Neuronetics Appoints New Chief Financial Officer

Jul 3, 2025, 8:00 AM EDT - 1 year ago

Neuronetics Registration statement: Registration Filing

Jun 10, 2025, 8:31 AM EDT - 1 year ago

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program

Jun 2, 2025, 4:30 PM EDT - 1 year ago

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

May 6, 2025, 8:30 AM EDT - 1 year ago

Neuronetics Earnings Call Transcript: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Neuronetics Quarterly report: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Neuronetics Earnings release: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Neuronetics Slides: Q1 2025

May 6, 2025, 7:10 AM EDT - 1 year ago

Neuronetics Reports First Quarter 2025 Financial and Operating Results

Apr 10, 2025, 8:00 AM EDT - 1 year ago

Neuronetics Proxy statement: Proxy Filing

Apr 10, 2025, 8:00 AM EDT - 1 year ago

Neuronetics Proxy statement: Proxy Filing

Mar 31, 2025, 8:31 AM EDT - 1 year ago

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Neuronetics Proxy statement: Proxy Filing

Mar 4, 2025, 8:30 AM EST - 1 year ago

Neuronetics Earnings Call Transcript: Q4 2024

Mar 4, 2025, 8:30 AM EST - 1 year ago

Neuronetics Annual report: Q4 2024

Mar 4, 2025, 8:30 AM EST - 1 year ago

Neuronetics Earnings release: Q4 2024

Mar 4, 2025, 8:30 AM EST - 1 year ago

Neuronetics Slides: Q4 2024

Mar 4, 2025, 7:10 AM EST - 1 year ago

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Feb 7, 2025, 7:54 AM EST - 1 year ago

Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock

Feb 6, 2025, 4:23 PM EST - 1 year ago

Neuronetics Announces Launch of Underwritten Public Offering of Common Stock

Jan 29, 2025, 8:31 AM EST - 1 year ago

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

Dec 10, 2024, 10:00 AM EST - 1 year ago

Neuronetics and Greenbrook TMS Announce Closing of Transaction

Dec 4, 2024, 2:30 PM EST - 1 year ago

Neuronetics Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 8:30 AM EST - 1 year ago

Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 12, 2024, 6:45 PM EST - 1 year ago

CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 8:30 AM EST - 1 year ago

Neuronetics Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Neuronetics Quarterly report: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Neuronetics Earnings release: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Neuronetics Slides: Q3 2024

Nov 12, 2024, 7:10 AM EST - 1 year ago

Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Neuronetics Proxy statement: Proxy Filing

Oct 29, 2024, 4:30 PM EDT - 1 year ago

Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call

Oct 14, 2024, 8:31 AM EDT - 2 years ago

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

Oct 9, 2024, 8:00 AM EDT - 2 years ago

Neuronetics Proxy statement: Proxy Filing

Oct 4, 2024, 8:33 AM EDT - 2 years ago

Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings

Oct 4, 2024, 8:00 AM EDT - 2 years ago

Neuronetics Proxy statement: Proxy Filing

Oct 4, 2024, 8:00 AM EDT - 2 years ago

Neuronetics Proxy statement: Proxy Filing

Oct 2, 2024, 8:00 AM EDT - 2 years ago

Neuronetics Proxy statement: Proxy Filing

Sep 25, 2024, 8:31 AM EDT - 2 years ago

Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents

Sep 19, 2024, 8:31 AM EDT - 2 years ago

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

Sep 17, 2024, 8:00 AM EDT - 2 years ago

Neuronetics Proxy statement: Proxy Filing

Sep 16, 2024, 8:32 AM EDT - 2 years ago

NeuroStar® Releases Software Upgrades to Elevate Patient Care

Sep 3, 2024, 8:29 AM EDT - 2 years ago

NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

Aug 15, 2024, 8:00 AM EDT - 2 years ago

Neuronetics Proxy statement: Proxy Filing

Aug 14, 2024, 3:00 PM EDT - 2 years ago

Neuronetics Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Aug 14, 2024, 8:00 AM EDT - 2 years ago

Neuronetics Proxy statement: Proxy Filing

Aug 13, 2024, 8:00 AM EDT - 2 years ago

Neuronetics Proxy statement: Proxy Filing

Aug 12, 2024, 8:30 AM EDT - 2 years ago

Neuronetics Earnings Call Transcript: Q2 2024

Aug 12, 2024, 8:30 AM EDT - 2 years ago

Neuronetics Quarterly report: Q2 2024

Aug 12, 2024, 8:30 AM EDT - 2 years ago

Neuronetics Earnings release: Q2 2024

Aug 12, 2024, 8:30 AM EDT - 2 years ago

Neuronetics Slides: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Neuronetics Proxy statement: Proxy Filing

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Neuronetics Proxy statement: Proxy Filing

Aug 12, 2024, 7:15 AM EDT - 2 years ago

Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge

Aug 12, 2024, 7:10 AM EDT - 2 years ago

Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results

Aug 1, 2024, 8:29 AM EDT - 2 years ago

NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month

Jul 30, 2024, 8:30 AM EDT - 2 years ago

Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors

Jul 29, 2024, 8:30 AM EDT - 2 years ago

Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call